Patents show all

Uluru has 3 licensable patents.
42Applications27Issued

Clinical Trials show all

2N/A

SEC Filings show all

8-K11810-Q29D1010-K9S-11

SEC Form D Funding Events

DateOfferedSoldType
2015-04-20$500,000$500,000Debt, Option to Acquire, Security to be Acquired
2014-03-14$138,600$42,600Equity, Option to Acquire, Security to be Acquired
2013-07-08$87,000$87,000Equity
2013-04-15$91,250$58,250Equity
2013-01-10$3,800,000$400,000Equity, Option to Acquire, Security to be Acquired
2012-07-10$2,210,000$2,210,000Debt, Option to Acquire, Security to be Acquired
2006-09-26UnknownUnknownOther (Paper Filing)

Key Executives

  • Kerry P. Gray
    Executive Officer, Director
  • Terrance K. Wallberg
    Executive Officer
  • Jeffrey B. Davis
    Director
  • Jeffrey A. Stone
    Director
  • Helmut Kerschbaumer
    Director
  • Klaus Kuehne
    Director